09/02/2026
You cannot detect what you don’t recover.
As testing advances toward greater sensitivity, sample preparation becomes critical to recovering rare disease-associated molecules. Efficiently recovering, concentrating, and quantifying DNA from larger blood and plasma inputs is essential to detecting disease at the lowest levels.
Commercial shipments of our new ™ System are now underway in North America. The platform integrates nucleic acid extraction, concentration, and quantification into a single automated workflow, replacing fragmented protocols with a standardized process designed to reduce hands-on labor, variability, and operating costs.
Read the full press release: https://na2.hubs.ly/H07BwVH0
